Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity

• Published in: Journal of neuroimmunology 1995-06, Vol.59 (1), p.57-63
• Main Authors: Demissie, Sossiena, Rogers, Carolyn F., Hiramoto, Nancy S., Ghanta, Vithal K., Hiramoto, raymond N.
• Format: Article
• Language: English
• Subjects: Adrenocorticotropic hormone; Adrenocorticotropic Hormone - pharmacology; Animals; Arecoline; Arecoline - pharmacology; Brain - drug effects; Cisterna Magna - drug effects; Conditioned response; Conditioning (Psychology) - drug effects; Female; Killer Cells, Natural - drug effects; Mice; Mice, Inbred BALB C; Natural killer cell activity
• ISSN: 0165-5728; 1872-8421
• DOI: 10.1016/0165-5728(95)00025-W

The central nervous system plays an active role in the regulation of the immune system. Modulation of immune activities appears to be in part under the control of the hypothalamic-pituitary-adrenal (HPA) axis. We investigated the effect of a muscarinic cholinergic agonist, arecoline, which stimulates the secretion of corticotropin-releasing hormone (CRF) and adrenocorticotropic hormone (ACTH) on the immune system. In this report we demonstrate that peripherally administered arecoline or ACTH can increase activity of pre-activated NK cells. Second, we show that central administration of arecoline at a dose too low to alter peripheral events is sufficient to induce a significant increase in the activity of pre-activated natural killer (NK) cells. Finally, we demonstrate by using a Pavlovian conditioning paradigm that the pairing of a novel odor (camphor) with administration of arecoline can be used to alter NK cell activity. Subsequent to the conditioning trial, exposure to the odor alone is sufficient to raise NK cell activity. From these observations, we infer that the pathway(s) that are conditioned reside in sites located within the CNS and the conditioned response is evoked in the peripheral compartment (NK cell activity).